Achillion Overview
- Year Founded
-
1998
- Status
-
Acquired/Merged
- Employees
-
56
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$1.06B
Achillion General Information
Description
Developer of innovative small-molecule drugs designed to transform the lives of patients and families affected by diseases of the complement system, an integral part of the innate immune system.
Contact Information
Website
www.achillion.comCorporate Office
- 121 Seaport Boulevard
- Boston, MA 02210
- United States
Corporate Office
- 121 Seaport Boulevard
- Boston, MA 02210
- United States
Achillion Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 16. Merger/Acquisition | 28-Jan-2020 | $1.06B | Completed | Generating Revenue | ||
| 15. Secondary Transaction - Open Market | 31-Dec-2016 | Completed | Generating Revenue | |||
| 14. 2PO | 27-Feb-2013 | Completed | Clinical Trials - Phase 2 | |||
| 13. Secondary Transaction - Open Market | 21-Sep-2012 | Completed | Clinical Trials - Phase 2 | |||
| 12. PIPE | 30-Aug-2012 | Completed | Clinical Trials - Phase 2 | |||
| 11. 2PO | 21-Jun-2011 | Completed | Clinical Trials - Phase 2 | |||
| 10. PIPE | 23-Aug-2010 | Completed | Clinical Trials - Phase 2 | |||
| 9. Secondary Transaction - Open Market | 31-Dec-2008 | Completed | Clinical Trials - Phase 2 | |||
| 8. PIPE | 14-Aug-2008 | $31.1M | $188M | Completed | Clinical Trials - Phase 2 | |
| 7. IPO | 26-Oct-2006 | $51.8M | $156M | Completed | Clinical Trials - Phase 2 |
Achillion Comparisons
Industry
Financing
Details
Achillion Competitors (25)
One of Achillion’s 25 competitors is IFM Therapeutics, a Venture Capital-Backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| IFM Therapeutics | Venture Capital-Backed | Boston, MA | ||||
| Meditope Biosciences | Formerly VC-backed | Pasadena, CA | ||||
| Centrose | Venture Capital-Backed | Madison, WI | ||||
| NGM Biopharmaceuticals | Private Equity-Backed | South San Francisco, CA | ||||
| Sangamo Therapeutics | Formerly VC-backed | Richmond, CA |
Achillion Patents
Achillion Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3193488-A1 | Pharmaceutical compounds for the treatment of complement mediated disorders | Pending | 23-Sep-2020 | ||
| EP-4216946-A1 | Pharmaceutical compounds for the treatment of complement mediated disorders | Pending | 23-Sep-2020 | ||
| EP-4216946-A4 | Pharmaceutical compounds for the treatment of complement mediated disorders | Pending | 23-Sep-2020 | ||
| US-20250171423-A1 | Pharmaceutical compounds for the treatment of complement mediated disorders | Pending | 23-Sep-2020 | ||
| WO-2022066774-A1 | Pharmaceutical compounds for the treatment of complement mediated disorders | Inactive | 23-Sep-2020 | C07D409/12 |
Achillion Signals
Achillion Former Investors (28)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Advent International | PE/Buyout | Minority | ||
| Atlas Venture | Venture Capital | Minority | ||
| BB Biotech | Asset Manager | Minority | ||
| Bear Stearns Health InnoVentures Management | Venture Capital | Minority | ||
| Connecticut Innovations | Venture Capital | Minority |
Achillion ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Achillion FAQs
-
When was Achillion founded?
Achillion was founded in 1998.
-
Where is Achillion headquartered?
Achillion is headquartered in Boston, MA.
-
What is the size of Achillion?
Achillion has 56 total employees.
-
What industry is Achillion in?
Achillion’s primary industry is Drug Discovery.
-
Is Achillion a private or public company?
Achillion is a Private company.
-
What is the current valuation of Achillion?
The current valuation of Achillion is .
-
What is Achillion’s current revenue?
The current revenue for Achillion is .
-
How much funding has Achillion raised over time?
Achillion has raised $475M.
-
Who are Achillion’s investors?
Advent International, Atlas Venture, BB Biotech, Bear Stearns Health InnoVentures Management, and Connecticut Innovations are 5 of 28 investors who have invested in Achillion.
-
Who are Achillion’s competitors?
IFM Therapeutics, Meditope Biosciences, Centrose, NGM Biopharmaceuticals, and Sangamo Therapeutics are some of the 25 competitors of Achillion.
-
When was Achillion acquired?
Achillion was acquired on 28-Jan-2020.
-
Who acquired Achillion?
Achillion was acquired by Alexion.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process